EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    4.4.1.11 | Obesity |
25842377 |
Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity. |
ongoing research
unassigned |
2
0 |
| 4.4.1.11 | Obesity |
30824679 |
Erratum: Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity. |
ongoing research
unassigned |
2
0 |
| 4.4.1.11 | Obesity |
32111745 |
Oral Recombinant Methioninase Prevents Obesity in Mice on a High-fat Diet. |
ongoing research
therapeutic application
unassigned |
4
4
0 |
| 4.4.1.11 | Osteosarcoma |
28870899 |
Effective Metabolic Targeting of Human Osteosarcoma Cells In Vitro and in Orthotopic Nude-mouse Models with Recombinant Methioninase. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
4
2
0 |
| 4.4.1.11 | Osteosarcoma |
29374999 |
Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: Decoy, trap and kill chemotherapy moves toward the clinic. |
ongoing research
therapeutic application
unassigned |
2
2
0 |
| 4.4.1.11 | Osteosarcoma |
30725413 |
Methioninase Cell-Cycle Trap Cancer Chemotherapy. |
therapeutic application
unassigned |
3
0 |
| 4.4.1.11 | Osteosarcoma |
31519563 |
Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of Osteosarcoma. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
2
2
0 |
| 4.4.1.11 | Osteosarcoma |
31705268 |
The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model. |
ongoing research
unassigned |
3
0 |
| 4.4.1.11 | Osteosarcoma |
33813378 |
Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model. |
ongoing research
therapeutic application
unassigned |
4
2
0 |
| 4.4.1.11 | Ovarian Neoplasms |
10825143 |
Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
4
4 |
